BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6482312)

  • 1. Disposition of oxazepam in patients on maintenance hemodialysis.
    Ochs HR; Greenblatt DJ; Klehr U
    Klin Wochenschr; 1984 Aug; 62(16):765-7. PubMed ID: 6482312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal disease, age, and oxazepam kinetics.
    Murray TG; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1981 Dec; 30(6):805-9. PubMed ID: 7307429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose kinetics and dialyzability of oxazepam in renal insufficiency.
    Greenblatt DJ; Murray TG; Audet PR; Locniskar A; Koepke HH; Walker BR
    Nephron; 1983; 34(4):234-8. PubMed ID: 6877459
    [No Abstract]   [Full Text] [Related]  

  • 5. Disposition of oxazepam in relation to age, sex, and cigarette smoking.
    Ochs HR; Greenblatt DJ; Otten H
    Klin Wochenschr; 1981 Aug; 59(16):899-903. PubMed ID: 7278081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxazepam disposition in uremic patients.
    Odar-Cederlöf I; Vessman J; Alván G; Sjöqvist F
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):52-62. PubMed ID: 300542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.
    Sonne J; Boesgaard S; Poulsen HE; Loft S; Hansen JM; Døssing M; Andreasen F
    Br J Clin Pharmacol; 1990 Nov; 30(5):737-42. PubMed ID: 2271373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.
    Sonne J; Loft S; Døssing M; Boesgaard S; Andreasen F
    Br J Clin Pharmacol; 1991 Jun; 31(6):719-22. PubMed ID: 1867967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of High-Dose Oxazepam in Alcohol-Dependent Patients: Is There a Risk of Accumulation?
    Imbert B; Marsot A; Liachenko N; Simon N
    Ther Drug Monit; 2016 Apr; 38(2):253-8. PubMed ID: 26580099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cirrhosis and renal failure on the kinetics of clotiazepam.
    Ochs HR; Greenblatt DJ; Knüchel M
    Eur J Clin Pharmacol; 1986; 30(1):89-92. PubMed ID: 2872061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hemodialysis on the pharmacokinetics of theophylline in chronic renal failure.
    Kradjan WA; Martin TR; Delaney CJ; Blair AD; Cutler RE
    Nephron; 1982; 32(1):40-4. PubMed ID: 7177275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.
    Dreyfuss D; Shader RI; Harmatz JS; Greenblatt DJ
    J Clin Psychiatry; 1986 Oct; 47(10):511-4. PubMed ID: 3759915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic profile of oxazepam.
    Alván G; Odar-Cederlöf I
    Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy.
    Sonne J; Andreasen PB; Loft S; Døssing M; Andreasen F
    Hepatology; 1990 Jun; 11(6):951-6. PubMed ID: 2365292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate.
    Pilbrant A; Glenne PO; Sundwall A; Vessman J; Wretlind M
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):7-15. PubMed ID: 322447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.